IC-542

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameIC-542

Drug Alias NameIC-542

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodieterase 4 inhibitors

TargetsPhosphodieterase 4

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIcos Corporation

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesIcos Corporation

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A